Microfluidic Perfusion Devices with Patterned Hydrogels
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current drug development protocols rely on inadequate 2D monolayer cultures and animal models for preclinical drug testing, which fail to recapitulate the complex in vivo environment of cells embedded within extracellular matrices, limiting the accuracy of drug efficacy and toxicity assessments.
Innovation Solution
A microfluidic device with patterned hydrogels embedded with cells or microtissues is developed, allowing for the creation of a 3D cellular environment that mimics in vivo conditions, enabling precise control over cell seeding and real-time monitoring of biological responses through photomask-based stereolithography and photogelation of polymers.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of manufacture
If 2D monolayer cultures are used for drug testing, then the testing process is simple and cost-effective, but the accuracy of drug efficacy and toxicity assessments deteriorates because they fail to recapitulate the in vivo cellular environment
Solution Approach 1:
The patent transitions from 2D monolayer cultures to 3D microtissue constructs embedded in hydrogels within microfluidic devices. This dimensional change enables cells to self-organize into spheroids with core-shell structures that better mimic in vivo tissue architecture, thereby improving the accuracy of drug efficacy and toxicity assessments while maintaining experimental feasibility
Solution Approach 2:
The patent creates nested microtissue structures where different cell types are organized in concentric layers within hydrogel matrices. The microfluidic device further nests multiple microtissues in a single chip, enabling complex tissue-tissue interactions to be studied in a compact platform that maintains physiological relevance
2Reliability
If animal models are used for preclinical drug testing, then the physiological relevance is improved, but the complexity and ethical concerns of the testing protocol increase
Solution Approach 1:
The patent creates simplified human-relevant models by copying key physiological features of in vivo tissues into microfluidic devices. Human cells are cultured in 3D hydrogel matrices that replicate extracellular matrix properties, and microfluidic flow patterns mimic blood circulation, providing human-specific physiological relevance without requiring animal subjects
Solution Approach 2:
The patent segments complex physiological systems into discrete microtissue modules that can be independently cultured and then combined in the microfluidic device. This modular approach allows specific tissue types (tumor, stroma, endothelium) to be studied in isolation or in controlled combinations, simplifying the overall testing protocol while maintaining physiological interactions
3Measurement precision
If 3D microtissue models are implemented in microfluidic devices, then the physiological relevance and drug penetration assessment are improved, but the device fabrication and operation complexity increase
Solution Approach 1:
The patent employs self-organizing properties of cells to form 3D microtissues within the microfluidic device without requiring complex external patterning. Cells automatically aggregate into spheroids with physiologically relevant structures when provided with appropriate hydrogel matrices and flow conditions, eliminating the need for sophisticated lithography or robotic assembly
Solution Approach 2:
The patent uses photopolymerization to dynamically change the physical state of hydrogel matrices from liquid precursors to solid gels, enabling precise spatial and temporal control over microtissue formation. This parameter change allows simple device fabrication while achieving complex 3D cellular architectures through controlled polymerization kinetics and light patterning
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach provides a more physiologically relevant platform for drug testing, enabling real-time monitoring of drug effects and mechanical behavior of microtissues, and allows for the assessment of drug penetration and efficacy in a 3D environment, overcoming the limitations of traditional 2D models.
Implementation Method 1
The disclosure provides a photomask-based stereolithography approach coupled with the photogelation of polymers to create patterned 3D structures
Implementation Method 2
a photomask-based stereolithography approach coupled with the photogelation of polymers to create patterned 3D structures
Data Source
AI summary
The disclosure provides for microfluidic devices comprising patterned hydrogels with embedded cells or microtissues.